The DDAH-ADMA-NOS Pathway

An increasing number of reports in the literature indicate that endogenously produced inhibitors of nitric oxide synthase (NOS), particularly asymmetric dimethylarginine (ADMA), regulate nitric oxide generation in disease states. This article describes the biology of ADMA and the implications for cardiovascular physiology and pathophysiology.

[1]  P. Tsao,et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.

[2]  Pamela A. Silver,et al.  State of the Arg Protein Methylation at Arginine Comes of Age , 2001, Cell.

[3]  S. Clarke,et al.  Protein methylation. , 1993, Current opinion in cell biology.

[4]  G. Rosen,et al.  Mechanism of Superoxide Generation by Neuronal Nitric-oxide Synthase* , 1999, The Journal of Biological Chemistry.

[5]  P. Tsao,et al.  Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. , 1999, Circulation.

[6]  S. Moncada,et al.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.

[7]  M. Marletta,et al.  NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. , 1993, Biochemistry.

[8]  M. Kimoto,et al.  Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. , 1989, The Journal of biological chemistry.

[9]  D. Webb,et al.  Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. , 1998, Kidney international.

[10]  C. Zoccali,et al.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study , 2001, The Lancet.

[11]  M. Kimoto,et al.  Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats. , 1987, Archives of biochemistry and biophysics.

[12]  M. Kimoto,et al.  Dimethylarginine:pyruvate aminotransferase in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. , 1990, The Journal of biological chemistry.

[13]  M. Kimoto,et al.  Detection of NG,NGDimethylarginine Dimethylaminohydrolase in Human Tissues Using a Monoclonal Antibody , 1995 .

[14]  T. Lehtimäki,et al.  Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine , 2001, The Lancet.

[15]  S. Homma,et al.  Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Cooke,et al.  Does ADMA cause endothelial dysfunction? , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[17]  P. Vallance,et al.  Effects of guanidino and uremic compounds on nitric oxide pathways. , 1994, Kidney international.

[18]  M. Fox,et al.  Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. , 2000, Genomics.

[19]  H. Tohgi,et al.  Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease , 2001, Neuroscience Letters.

[20]  M. Kimoto,et al.  Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats. , 1987, Biochemical and biophysical research communications.

[21]  J. Mcdermott,et al.  Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. , 1976, The Biochemical journal.

[22]  Ian G. Charles,et al.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. , 1999, The Biochemical journal.

[23]  P. Vallance,et al.  Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Tsao,et al.  Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.

[25]  J. Deanfield,et al.  Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. , 2001, Kidney international.

[26]  J. Cooke,et al.  Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. , 1999, Circulation.